Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study record page now displays a 403 error, replacing the full trial details with an access-restricted page. This change prevents users from viewing core information about the trial, including its design, eligibility criteria, locations, and related documents.SummaryDifference19%

- Check27 days agoChange DetectedThe page now shows revision: v3.7.0, replacing the previous revision: v3.6.6. This indicates a new version of the page content without changing the study details.SummaryDifference0.0%

- Check41 days agoChange DetectedA new page revision tag v3.6.6 was added to the page metadata. The previous revision tag v3.6.5 was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedA new NIH grant/contract identifier (2018) was added to the study's identifiers, representing funding information for the trial.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.6.5 has been added to the page. The Plain Language Summary section was removed and the Revision: v3.6.4 entry was deleted, affecting how the trial information is presented.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.